These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 38426198)

  • 41. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.
    Montano-Loza AJ; Angulo P; Meza-Junco J; Prado CM; Sawyer MB; Beaumont C; Esfandiari N; Ma M; Baracos VE
    J Cachexia Sarcopenia Muscle; 2016 May; 7(2):126-35. PubMed ID: 27493866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study.
    Ebrahimi F; Hagström H; Sun J; Bergman D; Shang Y; Yang W; Roelstraete B; Ludvigsson JF
    J Hepatol; 2023 Dec; 79(6):1374-1384. PubMed ID: 37647992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice.
    Ilagan-Ying YC; Banini BA; Do A; Lam R; Lim JK
    Curr Gastroenterol Rep; 2023 Oct; 25(10):213-224. PubMed ID: 37768417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment.
    Ciardullo S; Vergani M; Perseghin G
    J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease.
    Musio A; Perazza F; Leoni L; Stefanini B; Dajti E; Menozzi R; Petroni ML; Colecchia A; Ravaioli F
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
    Liu H; Yerevanian A; Westerhoff M; Hastings MH; Guerra JRB; Zhao M; Svensson KJ; Cai B; Soukas AA; Rosenzweig A
    Diabetes; 2024 Feb; 73(2):260-279. PubMed ID: 37934943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis.
    Kuraji R; Sekino S; Kapila Y; Numabe Y
    Periodontol 2000; 2021 Oct; 87(1):204-240. PubMed ID: 34463983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sarcopenic obesity in cirrhosis-The confluence of 2 prognostic titans.
    Eslamparast T; Montano-Loza AJ; Raman M; Tandon P
    Liver Int; 2018 Oct; 38(10):1706-1717. PubMed ID: 29738109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinics in Liver Disease: Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty Liver Disease.
    Kawaguchi T; Takahashi H; Gerber LH
    Clin Liver Dis; 2023 May; 27(2):275-286. PubMed ID: 37024207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.
    Chrysavgis L; Ztriva E; Protopapas A; Tziomalos K; Cholongitas E
    World J Gastroenterol; 2020 Nov; 26(42):6514-6528. PubMed ID: 33268944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myosteatosis in nonalcoholic fatty liver disease: An exploratory study.
    De Munck TJI; Verhaegh P; Lodewick T; Bakers F; Jonkers D; Masclee AAM; Verbeek J; Koek GH
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101500. PubMed ID: 32828745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications.
    Fernández-Mincone T; Contreras-Briceño F; Espinosa-Ramírez M; García-Valdés P; López-Fuenzalida A; Riquelme A; Arab JP; Cabrera D; Arrese M; Barrera F
    Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1141-1157. PubMed ID: 32811209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease.
    Chun HS; Lee M; Lee HA; Lee S; Kim S; Jung YJ; Lee C; Kim H; Lee HA; Kim HY; Yoo K; Kim TH; Ahn SH; Kim SU
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2298-2307.e18. PubMed ID: 36462755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass.
    Choe EK; Kang HY; Park B; Yang JI; Kim JS
    J Clin Med; 2018 Sep; 7(10):. PubMed ID: 30274215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD.
    Linge J; Ekstedt M; Dahlqvist Leinhard O
    JHEP Rep; 2021 Feb; 3(1):100197. PubMed ID: 33598647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sarcopenia, healthy living, and mortality in patients with chronic liver diseases.
    Van Dongen C; Paik JM; Harring M; Younossi Y; Price JK; Kabbara K; Golabi P; Younossi ZM
    Hepatol Commun; 2022 Nov; 6(11):3140-3153. PubMed ID: 35950286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Cai C; Song X; Chen Y; Chen X; Yu C
    Hepatol Int; 2020 Jan; 14(1):115-126. PubMed ID: 31290072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease.
    Chung GE; Kim MJ; Yim JY; Kim JS; Yoon JW
    J Obes Metab Syndr; 2019 Jun; 28(2):129-138. PubMed ID: 31294345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sarcopenia and chronic liver diseases.
    Hsu CS; Kao JH
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1229-1244. PubMed ID: 30791794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. "Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD".
    Hanna DJ; Jamieson ST; Lee CS; Pluskota CA; Bressler NJ; Benotti PN; Khurana S; Rolston DDK; Still CD
    Obes Sci Pract; 2021 Oct; 7(5):629-645. PubMed ID: 34631140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.